|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
4339600 |
| 003 |
ICU |
| 005 |
20031020111100.0 |
| 008 |
990927s2000 enk 001 0 eng c |
| 010 |
|
|
|a 99048963
|
| 015 |
|
|
|a GBA0-Z4087
|
| 020 |
|
|
|a 0521622638 (hardback)
|
| 035 |
|
|
|a MIUGATD8880-B
|
| 035 |
|
|
|a (MiU)notisATD8880
|
| 035 |
|
|
|a (OCoLC)42476292
|
| 035 |
|
|
|a 90066714
|
| 040 |
|
|
|a NLM
|c NLM
|d UKM
|d EYM
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 060 |
1 |
0 |
|a QZ 266
|b C2199 2000
|
| 082 |
0 |
4 |
|a 616.994079
|2 21
|
| 245 |
0 |
0 |
|a Cancer vaccines and immunotherapy /
|c edited by Peter L. Stern, Peter C.L. Beverley, and Miles W. Carroll.
|
| 260 |
|
|
|a Cambridge, UK ;
|a New York, NY :
|b Cambridge University Press,
|c 2000.
|
| 300 |
|
|
|a p. ;
|c cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 500 |
|
|
|a Includes index.
|
| 505 |
0 |
0 |
|g 1.
|t Immunity and cancer /
|r Peter C. L. Beverley, Miles W. Carroll and Peter L. Stern --
|g 2.
|t Immunotherapy of bladder cancer /
|r Anton B. Alexandroff and Keith James --
|g 3.
|t Poxviruses as vectors for cancer immunotherapy /
|r Miles W. Carroll and Nicholas P. Restifo --
|g 4.
|t Vaccinia-based human papillomavirus vaccines in cervical cancer /
|r Leszek K. Borysiewicz and Stephen Man --
|g 5.
|t Vaccine delivery and immunosuppression in cervical cancer /
|r Michael P. Rudolf, Laurie A. Small and Markwin P. Velders /
|r [et al.] --
|g 6.
|t Vaccines for colon cancer /
|r Howard L. Kaufman and Jeffrey Schlom --
|g 7.
|t MUCl vaccines and breast cancer /
|r Joyce Taylor-Papadimitriou, Joy Burchell and David W. Miles --
|g 8.
|t Anti-idiotypic vaccination /
|r Lindy G. Durrant, Ian Spendlove and R. Adrian Robins --
|g 9.
|t Immunotherapy and vaccination against Epstein-Barr virus-associated cancer /
|r John R. Arrand --
|g 10.
|t Serologically identified tumour antigens as cancer vaccines /
|r Ugur Sahin, Ozlem Tureci and Michael Pfreundschuh --
|g 11.
|t CTL-defined cancer vaccines in melanoma and other epithelial cancers /
|r Elke Jager, Dirk Jager and Alexander Knuth --
|g 12.
|t DNA vaccines against B-cell tumours /
|r Freda K. Stevenson, Delin Zhu and Myfanwy Spellerberg /
|r [et al.] --
|g 13.
|t Dendritic cell approaches to immunotherapy /
|r Malcolm Adams, Bharat Jasani and Camilo A. L. S. Colaco /
|r [et al.] --
|g 14.
|t Overview /
|r Peter L. Stern, Peter C. L. Beverley and Miles W. Carroll --
|g 15.
|t Recent developments /
|r Peter L. Stern.
|
| 650 |
1 |
2 |
|a Neoplasms
|x therapy.
|
| 650 |
2 |
2 |
|a Immunotherapy.
|
| 650 |
2 |
2 |
|a Vaccines.
|
| 650 |
|
0 |
|a Cancer
|x Prevention.
|0 http://id.loc.gov/authorities/subjects/sh85019527
|
| 650 |
|
0 |
|a Cancer
|x Immunotherapy.
|0 http://id.loc.gov/authorities/subjects/sh87002642
|
| 650 |
|
0 |
|a Cancer
|x Immunological aspects.
|0 http://id.loc.gov/authorities/subjects/sh85019512
|
| 650 |
|
7 |
|a Cancer
|x Immunotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845386
|
| 650 |
|
7 |
|a Cancer vaccines.
|2 fast
|0 http://id.worldcat.org/fast/fst00845608
|
| 700 |
1 |
|
|a Stern, Peter L.
|0 http://id.loc.gov/authorities/names/n93805008
|
| 700 |
1 |
|
|a Beverley, Peter C. L.
|0 http://id.loc.gov/authorities/names/n85063755
|1 http://viaf.org/viaf/21106992
|
| 700 |
1 |
|
|a Carroll, Miles W.
|q (Miles William),
|d 1965-
|0 http://id.loc.gov/authorities/names/n99803155
|1 http://viaf.org/viaf/48564907
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 7018fa99-76c8-5a53-aaeb-a65e3ef9acec
|s 6834c192-8e8d-5e27-9903-94153ea21379
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.I45 C365 2000
|l JCL
|c JCL-Sci
|i 4676899
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.I45 C365 2000
|l JCL
|c JCL-Sci
|e MAYB
|e CRERAR
|b 56500677
|i 6925406
|
